Osteoporosis International

, Volume 18, Issue 10, pp 1355–1362 | Cite as

Cardiovascular diseases and future risk of hip fracture in women

  • U. Sennerby
  • B. Farahmand
  • A. Ahlbom
  • S. Ljunghall
  • K. Michaëlsson
Original Article



We used a population-based case-control study in women and linkage to the Swedish in-patient register to examine if there is an increased risk of hip fracture after a cardiovascular disease. There was a substantially increased risk of hip fracture after a diagnosis of a cardiovascular disease.


Recent data have indicated that cardiovascular diseases (CVDs) might have a relationship to osteoporosis, which may explain the increased risk of mortality after hip fracture. It is uncertain, however, whether there is an increased risk of fracture after any cardiovascular disease and in subgroups of CVDs. The objective of this study was to determine whether there are associations between CVD and future hip fracture risk. Knowledge of the risk pattern would lead to better understanding of common pathologic pathways of osteoporosis and CVD.


We conducted a population-based case-control study of 1,327 incident hip fracture cases and 3,170 randomly selected population controls among women 50–81 years old in Sweden. Information on cardiovascular and other diseases before the fracture was obtained by linkage to the Swedish National Inpatient Register. Odds ratios (OR) and 95% confidence intervals (CI) where calculated by unconditional logistic regression.


Before study entry, CVDs were diagnosed more than twice as commonly among fracture cases (25%) as among controls (12%). Also, after adjustment for variables including several chronic diseases, we found a doubled risk of hip fracture after a CVD event (OR 2.38; 95% CI 1.92–2.94). There was a gradient increase in risk of hip fracture with increasing number of hospitalizations for CVD and highest fracture risk occurred the first year after the CVD event. Hypertension, heart failure, and cerebrovascular lesions remained independent risk factors, with 2- to 3-fold increases in odds ratios, even after mutual adjustments for other CVDs.


There was a substantially increased risk of hip fracture in women after a diagnosis of a CVD, a finding compatible with the concept of common pathologic pathways for osteoporotic fractures and CVD.


Cardiovasculare disease Cerebrovascular laesion Heart failure Hip fracture Hypertension Osteoporosis 


  1. 1.
    Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in and women: an observational study. Lancet 353:878–882PubMedCrossRefGoogle Scholar
  2. 2.
    Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Mortality after osteoporotic fractures. Osteoporosis Int 15:38–42CrossRefGoogle Scholar
  3. 3.
    Farahmand BY, Michaelsson K, Ahlbom A, Ljunghall S, Baron JA (2005) Survival after hip fracture. Osteoporosis Int 16:1583–1590CrossRefGoogle Scholar
  4. 4.
    Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporosis Int 15:389–395CrossRefGoogle Scholar
  5. 5.
    Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification of 25-year period: The Framingham Heart Study. Calcif Tissue Int 68:271–276PubMedCrossRefGoogle Scholar
  6. 6.
    von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278PubMedCrossRefGoogle Scholar
  7. 7.
    Marcovitz PA, Tran HH, Franklin BA, O’Neill WW, Yerkey M, Boura J, Kleerkoper M, Dickinson CZ (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96:1059–1063PubMedCrossRefGoogle Scholar
  8. 8.
    Collin-Osdoby P (2004) Regulation of vascular calcification by osteoclast regulatory factors RANK-L and osteoprotegerin. Circ Res 95:1046–1057PubMedCrossRefGoogle Scholar
  9. 9.
    Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANK-L regulated osteoclast differentiation. J Clin Inv 114(4):475–484CrossRefGoogle Scholar
  10. 10.
    Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocr Rev 13:66–80PubMedCrossRefGoogle Scholar
  11. 11.
    Kwan Tat S, Padrines M, Theoleyre S, Heyman D, Fortun Y (2004) IL-6, RANK TNF-alpha/IL-1: interrelation in bone resorption. Cytokine Growth Factor Rev 15:49–60PubMedCrossRefGoogle Scholar
  12. 12.
    Theill LE, Boyle WJ, Penninger JM (2002) RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol 20:795–823PubMedCrossRefGoogle Scholar
  13. 13.
    Cappucio FP, Meilahn E, Zmuda JM, Cauley JA (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 18:354(9183):971–975CrossRefGoogle Scholar
  14. 14.
    Johnell O, Kanis JA, Oden A, Johansson H, DeLaet C, Delmas P, Eisman JA, Fujuwara S, Kroger H, Mellström D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194PubMedCrossRefGoogle Scholar
  15. 15.
    Mussolino ME, Madans JH, Gillum RF (2003) Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol 13(10):692–697, NovPubMedCrossRefGoogle Scholar
  16. 16.
    Michaelsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S (1999) Oral-contraceptive use and risk of hip fracture:a case control study. Lancet 1;353(9163):1481–1484CrossRefGoogle Scholar
  17. 17.
    Michaelsson K, Baron J, Farahmand BY, Johnell O, Magnusson C, Persson PG, Persson I, Ljunghall S (1998) Hormone replacement therapy and risk of hip fracture: population based case-control study. The Hip Fracture Study Group. BMJ 20;316(7148):1858–1863Google Scholar
  18. 18.
    Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C; Prospective Epidemiological Risk Factors Study Group (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259:598–605PubMedCrossRefGoogle Scholar
  19. 19.
    Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246–4253PubMedCrossRefGoogle Scholar
  20. 20.
    Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912–1920PubMedCrossRefGoogle Scholar
  21. 21.
    Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Review; Osteoporosis and cardiovascular disease. Brittle Bones and Boned Arteries. Is there a link? Endocrine 23(1):1–10CrossRefGoogle Scholar
  22. 22.
    Bevilacqua M, Dominguez LJ, Rosini S, Bargallo M (2005) Bisphonates and atherosclerosis: why? Lupus 14(9):773–779PubMedCrossRefGoogle Scholar
  23. 23.
    Power ML, Heaney RP, Kalkwarf HJ, Pitkin RM, Repke JT, Tsang RC, Schulkin J (1999) The role of calcium in health and disease. Am J Obstret Gynecol 181(6):1560–1569CrossRefGoogle Scholar
  24. 24.
    Zitterman A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Am J Obstet Gynecol 94(4):483–492Google Scholar
  25. 25.
    Fujita T (1985) Aging and calcium as an environmental factor. J Nutr Sci Vitaminol Suppl:S15–S19Google Scholar
  26. 26.
    Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link. Endocrine 23(1):1–10CrossRefGoogle Scholar
  27. 27.
    Baldini V, Mastropasqua M, Francucci CM, D’Erasmo E (2005) Cardiovascular disease and osteoporosis. J Endocrinol Invest 28(10 Suppl):69–72PubMedGoogle Scholar
  28. 28.
    Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631–637PubMedCrossRefGoogle Scholar
  29. 29.
    Tsutsui T, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Ohnishi M, Kinoshita M (2002) Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic heart failure. J Am Coll Cardiol 20;39(6):957–962CrossRefGoogle Scholar
  30. 30.
    Frostegard J, Wu R, Lemne C, Thulin T, Witzum JL, de Faire U (2003) Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci (Lond) 105(5):815–820Google Scholar
  31. 31.
    Koh JM, Young-Sun L, Yang Son K, Duk Jae K, Hong-Hee K, Joong-Yeol P, Ki-Up L, Ghi Su K (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21(7):1003–1011PubMedCrossRefGoogle Scholar
  32. 32.
    McLean RR, Jacues PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 13;350(20):2042–2049CrossRefGoogle Scholar
  33. 33.
    van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 13;350(20):2033–2041CrossRefGoogle Scholar
  34. 34.
    Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2;293(9):1082–1088CrossRefGoogle Scholar
  35. 35.
    Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D’Agostini RB (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction; Framingham Heart Study. Circulation 107:1486–1491PubMedCrossRefGoogle Scholar
  36. 36.
    Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G (2003) Homocysteine and essential hypertension. J Clin Pharmacol 43(12):1299–1306PubMedCrossRefGoogle Scholar
  37. 37.
    Douchi T, Yamamoto S, Oki T et al (2000) Difference in the effect of adiposity on bone density between pre- and postmenopausal women. Maturitas 34:261–266PubMedCrossRefGoogle Scholar
  38. 38.
    Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546–551PubMedCrossRefGoogle Scholar
  39. 39.
    Lechnik L, Register TC, Hsu FC et al (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646–651CrossRefGoogle Scholar
  40. 40.
    Rajala MW, Scherer PE (2003) Mini-review: the adipocyte-at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765–3773PubMedCrossRefGoogle Scholar
  41. 41.
    Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556PubMedCrossRefGoogle Scholar
  42. 42.
    Melton LJ 3rd, Brown RD Jr, Achenbach SJ, O’Fallon WM, Whisnant JP (2001) Long-Term fracture risk following ischemic stroke: a population-based study. Osteoporos Int 12:980–986PubMedCrossRefGoogle Scholar
  43. 43.
    Lindblad U, Ranstam L, Ranstam J, Peterson M (1993) Validity of register data on myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 21:3–9PubMedGoogle Scholar
  44. 44.
    Ingelsson E, Ärnlöv J, Sundström J, Lind L (2005) The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7:787–791PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2007

Authors and Affiliations

  • U. Sennerby
    • 1
  • B. Farahmand
    • 2
    • 3
  • A. Ahlbom
    • 2
  • S. Ljunghall
    • 3
  • K. Michaëlsson
    • 1
    • 4
  1. 1.Department of Surgical Sciences, Section of OrthopaedicsUniversity HospitalUppsalaSweden
  2. 2.Institute of Environmental MedicineKarolinska InstitutetStockholmSweden
  3. 3.Astra Zeneca R&DMölndalSweden
  4. 4.751 85 Uppsala Clinical Research Center (UCR)University HospitalUppsalaSweden

Personalised recommendations